NCT05173493View on ClinicalTrials.gov

The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

CompletedOBSERVATIONAL
Enrollment

670

Participants

Timeline

Start Date

December 30, 2021

Primary Completion Date

February 10, 2023

Study Completion Date

February 10, 2023

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Amoxicillin,Furazolidone

Amoxicillin-Furazolidone-containing quadruple group

DRUG

Amoxicillin,Levofloxacin

Amoxicillin-Levofloxacin-containing quadruple group

DRUG

Tetracycline,Furazolidone

Tetracycline-Furazolidone-containing quadruple group

Trial Locations (1)

Unknown

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
collaborator

Taian City Central Hospital

OTHER

collaborator

Dezhou People's Hospital

OTHER

collaborator

Weifang Medical University

OTHER

collaborator

The Affiliated Hospital of Qingdao University

OTHER

collaborator

Shengli Oilfield Hospital

OTHER

lead

Shandong University

OTHER

NCT05173493 - The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure | Biotech Hunter | Biotech Hunter